Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > SE. O. Melphalan Flufenamide+>>

---

SE. O. Melphalan Flufenamide+>>'s subsections
(*) EU Approval Date: 2022. 08.18
(*) UK Approval Date: 2022. 11.11
+Dexamethasone
>4 prior lines of therapy
>refractory to at least>
Company
Patent>EU Patent Number
TM
TM Web-Site

SE. O. Melphalan Flufenamide+>>'s products
This section has no products